Subash Jonnalagadda
Has grant
Department Head
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Subash Jonnalagadda is the Department Head at Rowan University in the United States. His research focuses on multiple myeloma treatment advancements, including drug repurposing and mechanisms of drug resistance. Recent publications highlight his contributions to understanding non-cancer medications' potential and innovative treatment strategies using nanocarrier systems.
Recent Grants
Grant: Close
MRI: Acquisition of a 400 MHz Nuclear Magnetic Resonance Spectrometer for the Transformative Advancement of Undergraduate Research
Open Date: 2018-08-01
Close Date: 2021-07-31
Articles (7)
Year:
2024
Multiple myeloma (MM) is a challenging hematological cancer which typically grows in bone marrow. MM accounts for 10% of hematological malignancies and 1.8% of cancers. The recent treatment strategies have significantly improved progression-free survival for MM patients in the last decade; however, a relapse for most MM patients is inevitable. In this review we discuss current treatment, important pathways for proliferation, survival, immune suppression, and resistance that could be targeted for future treatments.
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (3)
Manoj K. Pandey
Cooper Medical School of Rowan University
Robert Hesketh
Professor
Rowan University
Dhimant H. Desai
-
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.